COMMUNIQUÉS West-GlobeNewswire

Summit Therapeutics to Participate in Jefferies 2018 London Healthcare Conference
07/11/2018
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Therapeutics to Participate in Jefferies 2018 London Healthcare Conference Oxford, UK, and Cambridge, MA, US, 7 November 2018 – Summit Therapeutics plc (NASDAQ [...]
T2 Biosystems Reports Granting of Inducement Awards
07/11/2018
LEXINGTON, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
Surgery Partners, Inc. Announces Third Quarter 2018 Results
07/11/2018
Near Term Results Reflect Ongoing Traction of Strategic Growth Initiatives; Continued Investments to Drive Accelerated Growth in 2019 BRENTWOOD, Tenn., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: [...]
ProQR Announces Financial Results for the Third Quarter of 2018
07/11/2018
LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA [...]
Recro Pharma Reports Third Quarter 2018 Financial Results Raising Guidance for CDMO business for 2018
07/11/2018
Company to Host Conference Call Today at 8:00 AM ET MALVERN, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the [...]
Bellicum Pharmaceuticals to Present at the Jefferies 2018 London Healthcare Conference
07/11/2018
HOUSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results
07/11/2018
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
XOMA Reports Third Quarter 2018 Financial Results
07/11/2018
EMERYVILLE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator, today announced its third quarter 2018 financial results. “The third quarter of 2018 was [...]
CureVac to Present Preliminary Phase I Data on CV8102, an Intratumoral RNA-based Cancer Therapy, at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
07/11/2018
Data to be presented includes CV8102 as a single agent and in combination with anti-PD1 therapy TÜBINGEN, Germany and BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company [...]
Reata Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results and an Update on Development Programs
07/11/2018
IRVING, Texas, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today provided an update on the Company's product development programs and [...]
Protalix BioTherapeutics Reports 2018 Third Quarter Results and Provides Corporate Update
07/11/2018
CARMIEL, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX, TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
Arcturus Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results
07/11/2018
SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on the development and commercialization of therapeutics towards rare, infectious, fibrotic [...]
Tonix Pharmaceuticals Announces New Patent Coverage Protecting Tonmya®
07/11/2018
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) today announced that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Patent No. 10,117,936 [...]
R1 RCM Reports Third Quarter 2018 Results
07/11/2018
CHICAGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months [...]
Client Outlook Partners with PocketHealth to Give Patients Access to Imaging Records
07/11/2018
WATERLOO, Ontario, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Client Outlook, a leading provider of FDA Class II enterprise diagnostic and clinical image viewing solutions, announced today its partnership with PocketHealth to [...]
Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
Company to Host an Investor Conference Call on Wednesday, November 7, 2018 at 8:00 AM EST BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company [...]
BeiGene Reports Third Quarter 2018 Financial Results
07/11/2018
CAMBRIDGE, Mass. and BEIJING, China, Nov. 07, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Emblem Corp. announces new board appointments
07/11/2018
TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi to its Board of Directors (the [...]
BeiGene Initiates Global Head-to-Head Phase 3 Clinical Trial of Zanubrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
07/11/2018
CAMBRIDGE, Mass. and BEIJING, China, Nov. 07, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Pages